↓ Skip to main content

Design and evaluation of the immunogenicity and efficacy of a biomimetic particulate formulation of viral antigens

Overview of attention for article published in Scientific Reports, October 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter
9 X users
patent
1 patent

Readers on

mendeley
51 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Design and evaluation of the immunogenicity and efficacy of a biomimetic particulate formulation of viral antigens
Published in
Scientific Reports, October 2017
DOI 10.1038/s41598-017-13915-x
Pubmed ID
Authors
Abstract

Subunit viral vaccines are typically not as efficient as live attenuated or inactivated vaccines at inducing protective immune responses. This paper describes an alternative 'biomimetic' technology; whereby viral antigens were formulated around a polymeric shell in a rationally arranged fashion with a surface glycoprotein coated on to the surface and non-structural antigen and adjuvant encapsulated. We evaluated this model using BVDV E2 and NS3 proteins formulated in poly-(D, L-lactic-co-glycolic acid) (PLGA) nanoparticles adjuvanted with polyinosinic:polycytidylic acid (poly(I:C) as an adjuvant (Vaccine-NP). This Vaccine-NP was compared to ovalbumin and poly(I:C) formulated in a similar manner (Control-NP) and a commercial adjuvanted inactivated BVDV vaccine (IAV), all inoculated subcutaneously and boosted prior to BVDV-1 challenge. Significant virus-neutralizing activity, and E2 and NS3 specific antibodies were observed in both Vaccine-NP and IAV groups following the booster immunisation. IFN-γ responses were observed in ex vivo PBMC stimulated with E2 and NS3 proteins in both vaccinated groups. We observed that the protection afforded by the particulate vaccine was comparable to the licenced IAV formulation. In conclusion, the biomimetic particulates showed a promising immunogenicity and efficacy profile that may be improved by virtue of being a customisable mode of delivery.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 51 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Bachelor 11 22%
Student > Ph. D. Student 8 16%
Student > Master 6 12%
Researcher 6 12%
Lecturer > Senior Lecturer 2 4%
Other 7 14%
Unknown 11 22%
Readers by discipline
Readers by discipline Count As %
Immunology and Microbiology 11 22%
Veterinary Science and Veterinary Medicine 7 14%
Biochemistry, Genetics and Molecular Biology 5 10%
Agricultural and Biological Sciences 5 10%
Pharmacology, Toxicology and Pharmaceutical Science 4 8%
Other 5 10%
Unknown 14 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 February 2025.
All research outputs
#4,630,452
of 27,798,941 outputs
Outputs from Scientific Reports
#36,217
of 152,788 outputs
Outputs of similar age
#70,750
of 344,372 outputs
Outputs of similar age from Scientific Reports
#1,070
of 4,692 outputs
Altmetric has tracked 27,798,941 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 152,788 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 18.9. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 344,372 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 4,692 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.